OBJECTIVE: Dysregulation of the Hedgehog (Hh) pathway has been described in a variety of cancers, including cervical cancer, a disease which shares a common aetiology with vulval squamous cell carcinoma (VSCC). Here, we investigate a large number of primary VSCC cases for evidence of Hedgehog pathway activation and examine the implications of pathway activity on clinical outcomes in a cohort of patients with primary VSCC. METHODS: Archival histology blocks containing VSCC and histologically normal adjacent epithelium were retrieved from a cohort of 91 patients who underwent treatment for primary VSCC. Immunohistochemistry staining was undertaken to assess for the expression of key Hh pathway components (SHH, PTCH1, GLI1). A competing risks statistical model was used to evaluate the implications of the levels of key Hh pathway components on clinical outcomes. RESULTS: We show that 92% of primary VSCC cases over-expressed one or more components of the Hh signalling pathway when compared to the adjacent normal epithelium. While expression of SHH and GLI1 did not correlate with any clinicopathological criteria, over- or under-expression of PTCH1 was associated with a reduced or increased risk of developing a local disease recurrence, respectively. In VSCC arising on a background of Lichen Sclerosus, the risk of local recurrence was potentiated in cases where PTCH1 was under-expressed. CONCLUSIONS: Our findings reveal, for the first time, that the Hh pathway is activated in VSCC and that PTCH1 expression can be used as a biomarker to stratify patients and inform clinicians of the risk of their local recurrence, particularly in cases of VSCC associated with LS.

Birmingham Cancer Research UK Cancer Centre Institute of Cancer and Genomic Sciences University of Birmingham Birmingham West Midlands United Kingdom

Department of Clinical and Molecular Pathology and Laboratory of Molecular Pathology Palacky University Olomouc Moravia Czech Republic

Department of Histopathology Birmingham Women's NHS Foundation Trust Birmingham West Midlands United Kingdom

Pan Birmingham Gynaecological Cancer Centre City Hospital Birmingham West Midlands United Kingdom

See more in PubMed

Cancer Research UK (CRUK). Vulval Cancer Incidence Statistics. 2014. http://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk

Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–14. PubMed

Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, et al. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review. Gynecol Oncol. 2018;148(3):622–31. 10.1016/j.ygyno.2017.11.006 PubMed DOI

Yap J, O’Neill D, Nagenthiran S, Dawson CW, Luesley DM. Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva. BJOG. 2017;124(6):946–54. 10.1111/1471-0528.14560 PubMed DOI

Yap JK, Fox R, Leonard S, Ganesan R, Kehoe ST, Dawson CW, et al. Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecol Oncol. 2016;142(3):420–6. 10.1016/j.ygyno.2016.06.019 PubMed DOI

Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, et al. Cross-talk between Human Papillomavirus Oncoproteins and Hedgehog Signaling Synergistically Promotes Stemness in Cervical Cancer Cells. Sci Rep. 2016; 6:34377 10.1038/srep34377 PubMed DOI PMC

Wang Y, Jin G, Li Q, Wang Z, Hu W, Li P, et al. Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma. J Cancer. 2016; 7(14):2067–76. 10.7150/jca.15786 PubMed DOI PMC

Port RJ, Pinheiro-Maia S, Hu C, Arrand JR, Wei W, Young LS, et al. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells. J Pathol. 2013; 231(3):367–77. 10.1002/path.4245 PubMed DOI

Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3(12):903–11. 10.1038/nrc1229 PubMed DOI

Xuan YH, Jung HS, Choi YL, Shin YK, Kim HJ, Kim KH, et al. Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions. Mod Pathol. 2006;19(8):1139–47. 10.1038/modpathol.3800600 PubMed DOI

Giroux Leprieur E, Vieira T, Antoine M, Rozensztajn N, Rabbe N, Ruppert AM, et al. Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma. Clin Lung Cancer. 2016;17(4):301–8. 10.1016/j.cllc.2015.12.007 PubMed DOI

Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, et al. Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther. 2012;11(7):1587–97. 10.1158/1535-7163.MCT-11-1058 PubMed DOI PMC

Leonard S, Pereira M, Fox R, Gordon N, Yap J, Kehoe S, et al. Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomas. Gynecol Oncol. 2016;143(2):414–20. 10.1016/j.ygyno.2016.09.001 PubMed DOI

Hirsch FR, Varella-Garcia M, Bunn PA Jr., Di Maria MV, Veve R, Bremmes RM, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21(20):3798–807. 10.1200/JCO.2003.11.069 PubMed DOI

Collins SI, Constandinou-Williams C, Wen K, Young LS, Roberts S, Murray PG, et al. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res. 2009;69(9):3828–32. 10.1158/0008-5472.CAN-08-3099 PubMed DOI

Fine JP, G. R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc, 1999; 94:496–509.

Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet. 1996;14(1):78–81. 10.1038/ng0996-78 PubMed DOI

Wang YF, Chang CJ, Lin CP, Chang SY, Chu PY, Tai SK, et al. Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma. Head Neck. 2012;34(11):1556–61. 10.1002/hed.21958 PubMed DOI

Hanna A, Shevde LA. Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment. Mol Cancer. 2016;15:24 10.1186/s12943-016-0509-3 PubMed DOI PMC

Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999;353(9166):1777–83. PubMed

Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer cell 2015; 27(3): 342–353. 10.1016/j.ccell.2015.02.002 PubMed DOI PMC

Atwood S X, Whitson RJ & Oro AE. Advanced treatment for basal cell carcinomas. Cold Spring Harb Perspect Med. 2014; 4(7):a013581 10.1101/cshperspect.a013581 PubMed DOI PMC

Sharpe HJ, Pau G, Dijkgraaf GJ, Basset-Seguin N, Modrusan Z, Januario T, et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 2015. March 9; 27(3):327–41. 10.1016/j.ccell.2015.02.001 PubMed DOI PMC

Whitson RJ, Lee A, Urman NM, Mirza A, Yao CY, Brown AS, et al. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med. 2018; 24(3):271–281. 10.1038/nm.4476 PubMed DOI PMC

Samarzija I, Beard P. Hedgehog pathway regulators influence cervical cancer cell proliferation, survival and migration. Biochem Biophys Res Commun. 2012; 17;425(1):64–9. 10.1016/j.bbrc.2012.07.051 PubMed DOI

Chen H, Wang J, Yang H, Chen D, Li P. Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis. Oncol Lett. 2016;12(4):2664–2673. 10.3892/ol.2016.4932 PubMed DOI PMC

Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171–9. 10.1056/NEJMoa1113713 PubMed DOI PMC